Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor

Neuroscience

Volumn 165, Issue 4, 2010, Pages 1147-1158

  Krugel K ^a   Wurm, A ^a   Linnertz, R ^a   Pannicke, T ^a   Wiedemann, P ^a   Reichenbach, A ^a   Bringmann, A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

cellular swelling; erythropoietin; glia; glutamate; retina; VEGF

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CHLORIDE CHANNEL; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CELL SWELLING; CHANNEL GATING; CONTROLLED STUDY; DIABETES MELLITUS; EXOCYTOSIS; GLIA CELL; MUELLER CELL; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RETINA BIPOLAR GANGLION CELL; TRANSACTIVATION;

ANIMALS; CELL SIZE; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROPOIETIN; HOMEOSTASIS; JANUS KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROGLIA; OSMOSIS; RATS; RATS, LONG-EVANS; RETINA; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73749085951     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.11.035     Document Type: Article

References (50)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., and Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58 (2006) 281-341
2. Bellhorn R.W. Analysis of animal models of macular edema. Surv Ophthalmol 28 (1984) S520-S524
3. Bowman E.J., Siebers A., and Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85 (1988) 7972-7976
4. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90 (1983) 1301-1317
5. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6 (2005) 484-494
6. Bringmann A., Reichenbach A., and Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res 36 (2004) 241-249
7. Dietzel I., Heinemann U., and Lux H.D. Relations between slow extracellular potential changes, glial potassium buffering, and electrolyte and cellular volume changes during neuronal hyperactivity in cat brain. Glia 2 (1989) 25-44
8. Dmitriev A.V., Govardovskii V.I., Schwahn H.N., and Steinberg R.H. Light-induced changes of extracellular ions and volume in the isolated chick retina-pigment epithelium preparation. Vis Neurosci 16 (1999) 1157-1167
9. Dudek F.E., Obenhaus A., and Tasker J.G. Osmolality-induced changes in extracellular volume alter epileptiform bursts independent of chemical synapses in the rat: importance of non-synaptic mechanisms in hippocampal epileptogenesis. Neurosci Lett 120 (1990) 267-270
10. Fu Q.L., Wu W., Wang H., Li X., Lee V.W., and So K.F. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol 28 (2008) 317-329
11. Genc S., Koroglu T.F., and Genc K. Erythropoietin and the nervous system. Brain Res 1000 (2004) 19-31
12. Ghiardi G.J., Gidday J.M., and Roth S. The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vis Res 39 (1999) 2519-2535
13. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., and Remé C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8 (2002) 718-724
14. Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M., and Remé C. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24 (2004) 5651-5658
15. Gunnarson E., Song Y., Kowalewski J.M., Brismar H., Brines M., Cerami A., Andersson U., Zelenina M., and Aperia A. Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc Natl Acad Sci U S A 106 (2009) 1602-1607
16. Hernández C., Fonollosa A., García-Ramírez M., Higuera M., Catalán R., Miralles A., García-Arumí J., and Simó R. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 29 (2006) 2028-2033
17. Hirrlinger P.G., Wurm A., Hirrlinger J., Bringmann A., and Reichenbach A. Osmotic swelling characteristics of glial cells in the murine hippocampus, cerebellum, and retina in situ. J Neurochem 105 (2008) 1405-1417
18. Housley G.D., Bringmann A., and Reichenbach A. Purinergic signaling in special senses. Trends Neurosci 32 (2009) 128-141
19. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99 (2002) 10659-10664
20. Kimelberg H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50 (2005) 389-397
21. Kofuji P., Ceelen P., Zahs K.R., Surbeck L.W., Lester H.A., and Newman E.A. Genetic inactivation of an inwardly rectifying potassium channel (Kir41 subunit) in mice: phenotypic impact in retina. J Neurosci 20 (2000) 5733-5740
22. Larsen A.K., and Osborne N.N. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci 37 (1996) 2603-2611
23. Li Y., Lu Z.Y., Ogle M., and Wei L. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Neurochem Res 32 (2007) 2132-2141
24. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., and Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379 (1996) 645-648
25. Mori F., Hikichi T., Takahashi J., Nagaoka T., and Yoshida A. Dysfunction of active transport of blood-retinal barrier in patients with clinically significant macular edema in type 2 diabetes. Diabetes Care 25 (2002) 1248-1249
26. + siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir41 and AQP4 in specific membrane domains. Glia 26 (1999) 47-54
27. Newman E.A. Glial cell inhibition of neurons by release of ATP. J Neurosci 23 (2003) 1659-1666
28. Newman E.A., and Zahs K.R. Calcium waves in retinal glial cells. Science 275 (1997) 844-847
29. Newman E.A., and Zahs K.R. Modulation of neuronal activity by glial cells in the retina. J Neurosci 18 (1998) 4022-4028
30. + channel TASK-2 (KCNK5) by changes in cell volume. J Biol Chem 276 (2001) 43166-44374
31. Okutan O., Turkoglu O.F., Gok H.B., and Beskonakli E. Neuroprotective effect of erythropoietin after experimental cold injury-induced vasogenic brain edema in rats. Surg Neurol 70 (2008) 498-502
32. Ostwald P., Park S.S., Toledano A.Y., and Roth S. Adenosine receptor blockade and nitric oxide synthase inhibition in the retina: impact upon post-ischemic hyperemia and the electroretinogram. Vis Res 37 (1997) 3453-3461
33. Pannicke T., Iandiev I., Uckermann O., Biedermann B., Kutzera F., Wiedemann P., Wolburg H., Reichenbach A., and Bringmann A. A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol Cell Neurosci 26 (2004) 493-502
34. Pannicke T., Uckermann O., Iandiev I., Wiedemann P., Reichenbach A., and Bringmann A. Ocular inflammation alters swelling and membrane characteristics of rat Müller glial cells. J Neuroimmunol 161 (2005) 145-154
35. Pannicke T., Iandiev I., Wurm A., Uckermann O., vom Hagen F., Reichenbach A., Wiedemann P., Hammes H.-P., and Bringmann A. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes 55 (2006) 633-639
36. + channel from human kidney. J Biol Chem 273 (1998) 30863-30869
37. Skatchkov S.N., Eaton M.J., Shuba Y.M., Kucheryavykh Y.V., Derst C., Veh R.W., Wurm A., Iandiev I., Pannicke T., Bringmann A., and Reichenbach A. Tandem-pore domain potassium channels are functionally expressed in retinal (Müller) glial cells. Glia 53 (2006) 266-276
38. Storkebaum E., Lambrechts D., and Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26 (2004) 943-954
39. Uckermann O., Iandiev I., Francke M., Franze K., Grosche J., Wolf S., Kohen L., Wiedemann P., Reichenbach A., and Bringmann A. Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia 45 (2004) 59-66
40. Uckermann O., Vargová L., Ulbricht E., Klaus C., Weick M., Rillich K., Wiedemann P., Reichenbach A., Syková E., and Bringmann A. Glutamate-evoked alterations of glial and neuronal cell morphology in the guinea-pig retina. J Neurosci 24 (2004) 10149-10158
41. Uckermann O., Kutzera F., Wolf A., Pannicke T., Reichenbach A., Wiedemann P., Wolf S., and Bringmann A. The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 315 (2005) 1036-1045
42. Verdonck O., Lahrech H., Francony G., Carle O., Farion R., Van de Looij Y., Remy C., Segebarth C., and Payen J.F. Erythropoietin protects from post-traumatic edema in the rat brain. J Cereb Blood Flow Metab 27 (2007) 1369-1376
43. Wang L., Chopp M., Gregg S.R., Zhang R.L., Teng H., Jiang A., Feng Y., and Zhang Z.G. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab 28 (2008) 1361-1368
44. Wojchowski D.M., Gregory R.C., Miller C.P., Pandit A.K., and Pircher T.J. Signal transduction in the erythropoietin receptor system. Exp Cell Res 253 (1999) 143-156
45. Wurm A., Pannicke T., Wiedemann P., Reichenbach A., and Bringmann A. Glial cell-derived glutamate mediates autocrine cell volume regulation in the retina: activation by VEGF. J Neurochem 104 (2008) 386-399
46. 1 adenosine receptors in osmotic volume regulation of retinal glial cells in mice. Mol Vis 15 (2009) 1858-1867
47. Wurm A., Lipp S., Pannicke T., Linnertz R., Krügel U., Schulz A., Färber K., Zahn D., Grosse J., Wiedemann P., Chen J., Schöneberg T., Illes P., Reichenbach A., and Bringmann A. Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells (2009) Submitted for publication
48. Yasuhara T., Shingo T., and Date I. The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci 15 (2004) 293-307
49. Zhang J., Wu Y., Jin Y., Ji F., Sinclair S.H., Luo Y., Xu G., Lu L., Dai W., Yanoff M., Li W., and Xu G.T. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49 (2008) 732-742
50. Zhu B., Wang W., Gu Q., and Xu X. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp Eye Res 86 (2008) 375-382